NCT06859476View on ClinicalTrials.gov

Evaluation of Manzanilla® and Meticel Ofteno® 0.5% for Providing a Relief Sensation to the Eyes

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

168

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

August 31, 2026

Study Completion Date

October 31, 2026

Conditions
Ophthalmological Agent Toxicity
Interventions
DRUG

Manzanilla Sophia®

"Ophthalmic solution. Laboratorios Sophia, S.A. de C.V., Zapopan, Jalisco, Mexico.~Route of Administration: Ophthalmic."

DRUG

Meticel Ofteno® 0.5%

"Ophthalmic solution. Laboratorios Sophia, S.A. de C.V., Zapopan, Jalisco, Mexico.~Route of Administration: Ophthalmic."

All Listed Sponsors
lead

Laboratorios Sophia S.A de C.V.

INDUSTRY